In NSCLC samples, STYXL1, ATXN2L, UBAP2L, GRB7, DDX25, CTSG, SSB, CAPRIN1, CIRBP, DCP1A, ELAVL1, TIA1, EIF4G1, PRRC2C, MAPT, DHX9, OGFOD1, DDX3X, CSDE1, HABP4, PRKAA2, CELF1, DYRK3, DDX1 were significantly dysregulated in NSCLC. This evidence concerns the gene CELF1 and non-small cell lung carcinoma.